Schall Thomas J. 4
4 · Immuneering Corp · Filed Jun 13, 2024
Insider Transaction Report
Form 4
Immuneering CorpIMRX
Schall Thomas J.
Director
Transactions
- Award
Stock Option
2024-06-12+8,588→ 8,588 totalExercise: $1.54Exp: 2034-06-12→ Class A Common Stock (8,588 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 12, 2024, and will be fully vested and exercisable on June 12, 2025, or the date of the 2025 annual meeting of stockholders, whichever comes first.